QuadMedicine, Inc. (KOSDAQ:464490)

South Korea · Delayed Price · Currency is KRW

4,200.00

+165.00 (4.09%)

At close: Oct 16, 2026

Market Cap	48.22B
Revenue (ttm)	7.14B -46.5%
Net Income	-10.11B
EPS	-948.98
Shares Out	11.48M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	38,329
Open	4,035.00
Previous Close	4,035.00
Day's Range	3,905.00 - 4,270.00
52-Week Range	3,850.00 - 27,150.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About QuadMedicine

QuadMedicine, Inc. engages in research, development, and production of healthcare vaccination needles based on the microneedle array patch (MAP). The company develops vaccinations for children living in remote areas to protect them from infectious diseases, such as diphtheria, tetanus, polio, measles, and hepatitis B. The company focuses on technology integration for medical and pharmaceutical microneedle development. It also provides fundamental MAP research through prototyping to MAP production for clinical trials. The company was incorporate... [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 2016

Employees 104

Stock Exchange KOSDAQ

Ticker Symbol 464490

Full Company Profile

Financial Performance

In 2025, QuadMedicine's revenue was 10.70 billion, an increase of 14.99% compared to the previous year's 9.30 billion. Losses were -6.93 billion, 39.5% more than in 2024.

Financial Statements